Pancreatic cancer treatment and research: an international expert panel discussion. - Wikidata - wikimedia - TriplyDB

Pancreatic cancer treatment and research: an international expert panel discussion.

Pancreatic cancer treatment and research: an international expert panel discussion.

http://www.wikidata.org/entity/Q27690868

about

Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression.Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.Gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1.The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo.Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer Survival outcomes in patients with early stage, resected pancreatic cancer - a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens.Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS.Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.LITAF is a potential tumor suppressor in pancreatic cancer.

P2860

Q28542871-C1D7671C-54D9-4170-BC9A-8D0DBA763E7E Q33415922-AE73DCE6-7B74-4CDB-BB3C-98D14AAF67F1 Q33710074-8BA67B35-FA80-4507-ABC8-15EE6A01B4D8 Q34634833-EF9EB7B1-8301-4151-B0A6-751096A94D7E Q34656874-D0E7D028-253B-42EA-80F2-C0E81777C52D Q34738001-507C06FB-0DBF-47E8-A730-820992785EF1 Q35213046-FAA5BD2B-0E25-4CD0-B76C-30566B78E0C4 Q35787505-0C2148E4-31FF-4AD1-BA24-27C68B0660C5 Q36489812-A850E5C0-80ED-4896-BEEB-3528510DB68C Q36663677-9402AF10-B456-4710-B8EF-84621B60AFC8 Q37719839-1A6801EA-7824-433A-AA7F-3CE3C9168855 Q38903188-C501222C-BC63-4C56-8936-ED6CA15C4C66 Q40223950-2DC836F1-4B48-4512-9594-5D674BCB6C92 Q48098689-3EC94830-E44F-4883-AECC-C7EAF8D1BECF Q49725736-E3E0C76E-9ECA-469D-AA6D-F6CB635217EF

P2860

Pancreatic cancer treatment and research: an international expert panel discussion.

http://www.wikidata.org/entity/Q27690868

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pancreatic cancer treatment and research: an international expert panel discussion.

@ast

Pancreatic cancer treatment and research: an international expert panel discussion.

@en

Pancreatic cancer treatment and research: an international expert panel discussion.

@nl

type

label

Pancreatic cancer treatment and research: an international expert panel discussion.

@ast

Pancreatic cancer treatment and research: an international expert panel discussion.

@en

Pancreatic cancer treatment and research: an international expert panel discussion.

@nl

prefLabel

Pancreatic cancer treatment and research: an international expert panel discussion.

@ast

Pancreatic cancer treatment and research: an international expert panel discussion.

@en

Pancreatic cancer treatment and research: an international expert panel discussion.

@nl

P1433

Q27690868-E2DD6C51-19F0-4FB7-9E7E-800BF20FAC7B

P1476

Q27690868-99C8DF96-B07F-43C9-B0E8-B0578A19CE15

P2093

Q27690868-0355A94C-72F0-4983-A1BF-6A912CEDC039

Q27690868-20E629E5-B775-48B4-9DA3-1F1099268D1D

Q27690868-83CD788F-298C-4D7F-B82F-119C1CA88108

Q27690868-86094FC0-BD43-4C10-983D-22AD60A8FF4E

Q27690868-A2FD1F06-B7E7-48FB-AE5B-23FF72A3605F

Q27690868-AC01D8CE-311A-4AD5-99EE-37E3D69DDDE1

Q27690868-BCABBD13-E1F7-4D1B-9378-720E98FE3326

Q27690868-C3A172DE-95CC-4D1E-8105-6699637532B7

Q27690868-D63492BC-1789-4948-9047-435EDCCB5F8B

P2860

Q27690868-027DB18A-5EEC-497A-BB42-24CEBFEEE730

Q27690868-05637652-DCAB-46AA-A003-26116707B1F8

Q27690868-0C3A6DD1-3D74-4920-BF00-86CD90621246

Q27690868-0D4A5D68-E449-4969-BA58-490D0BE0A261

Q27690868-1ED62959-3A35-43AA-8A9B-75513BFAB51D

Q27690868-324867FD-2EA4-4CD3-B7A6-5A6884AD47F4

Q27690868-32DE9FB5-55AD-4E6C-88C3-4F3EFF4307F7

Q27690868-3937897D-9D6E-4B20-939A-5AEDFCD94976

Q27690868-53EB9B26-09E9-4377-9119-75169D497693

Q27690868-64475975-5AE8-4F3E-9B21-B601415CC213

P304

Q27690868-923AFEBF-B8EA-45F8-863E-D87BD345434A

P31

Q27690868-AF8C39EB-D6D4-493B-9EE8-03608CA92A95

P356

Q27690868-EDC28DE0-AE25-47DA-8EF6-83BC3F516942

P433

Q27690868-08A446D7-A0F5-487A-816F-56576E787406

P478

Q27690868-0440A5B7-DF19-46E7-8380-CD25F17B726E

P577

Q27690868-7913D25E-8832-4E7E-A70A-8CBD8F657060

P5875

Q27690868-96EFBB85-1CDF-4C0F-BCC0-025FC3FE60AE

P698

Q27690868-6F0ABB60-B82F-42B1-B8AF-A18175FEE3D5

P356

P1433

Annals of Oncology

P1476

Pancreatic cancer treatment and research: an international expert panel discussion.

@en

P2093

Berlin J

http://www.w3.org/2001/XMLSchema#string

Ducreux M

http://www.w3.org/2001/XMLSchema#string

Haller D

http://www.w3.org/2001/XMLSchema#string

Harper P

http://www.w3.org/2001/XMLSchema#string

Khayat D

http://www.w3.org/2001/XMLSchema#string

Schmoll HJ

http://www.w3.org/2001/XMLSchema#string

Sobrero A

http://www.w3.org/2001/XMLSchema#string

Tempero MA

http://www.w3.org/2001/XMLSchema#string

Van Cutsem E

http://www.w3.org/2001/XMLSchema#string

P2860

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Identification of pancreatic cancer stem cells

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

P304

1500-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDQ545

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49722717

http://www.w3.org/2001/XMLSchema#string

P698

21199884

http://www.w3.org/2001/XMLSchema#string